Welcome to Our Site
Our site provides investors with company-
specific data on publicy traded Israeli
stocks in Tel Aviv, Israeli companies 
traded globally as well as up-to-date
information on Israel and its economy.
Sign up for free digital directories   Sign up to receive free newsletter
Featured Companies
Content Providers
Sponsors
Company News
Haaretz.com, 16/4/2014 - Delek Group off-loading overseas assets
Read More >>
Globes, 16/4/2014 - Teva launches generic insomnia treatment in US
Brand Lunesta had $852 million in US sales in 2013.
Read More >>
Globes, 16/4/2014 - Cellcom picks Nokia Solutions for 4G network
Cellcom expects wide and high quality network deployment by the end of the year.
Read More >>
Globes, 9/4/2014 - Teva tax break in 2012 climbs to NIS 3.2b
This is the largest ever tax break received by a single Israeli company.
Read More >>

Find Company by Name:
Find Company by Industry:
Find Company by Stock Exchange:
Find Company by Index:
Find Company
by Language:
German French Spanish
Teva - PM Cameron visit Teva

Evogene - Evogen, Monsanto and Sygenta
Company Announcements
24/4/14
RedHill Biopharma
RedHill Biopharma and IntelGenx Provide an Update on FDA's Ongoing Review of the NDA for RHB-103 Oral Migraine Film >>
24/4/14
Teva
Pride-HD Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease >>
24/4/14
Kamada
Kamada Announces Significantly Improved Infusion Rate for Glassia® >>
24/4/14
Partner
Partner Communications Announces Receiving a Lawsuit and a Motion for the Recognition of This Lawsuit as a Class Action >>
22/4/14
BrainStorm Cell Therapeutics
BrainStorm Hosting Conference Call to Update Shareholders on Important Developments  >>
19/4/14
Teva
Teva Announces Supreme Court Denial of Request for Interim Relief to Stay Court of Appeals Ruling for COPAXONE® Patent Due to the Potential for the Company to Recover Patent Infringement Damages  >>
17/4/14
Teva
Teva Settles Patent Litigation with Pfizer on Celebrex®  >>
17/4/14
Delek Group
Delek Group's Subsidiary sells Delek Europe BV to Foriegn Fund For €355 Million >>

© Copyright 2014 | Terms & Conditions | Site Map | Contact Us | Tel Aviv Stock Exchange | Find a lawyer in Israel | Find a CPA in Israel | News releases from Israel Created by: Logics - פיתוח תוכנה ואינטרנט



Reprinted from the Equities Israel web site - www.equities.co.il